2022 Annual Shareholders’ Meeting Results

Stock Exchange Announcement
STOCK EXCHANGE LISTINGS: NEW ZEALAND (FPH), AUSTRALIA (FPH)

2022 Annual Shareholders’ Meeting Results

Auckland, New Zealand, 24 August 2022 - Fisher & Paykel Healthcare Corporation Limited advises that
all resolutions put to the company’s annual shareholders’ meeting held today were passed. The 11
resolutions were:
Resolution 1: To re-elect Lewis Gradon as a director.
Resolution 2: To re-elect Neville Mitchell as a director.
Resolution 3: To re-elect Donal O’Dwyer as a director.
Resolution 4: To elect Lisa McIntyre as a director.
Resolution 5: To elect Cather Simpson as a director.
Resolution 6: To authorise the Directors to fix the fees and expenses of the auditor.
Resolution 7: To approve the issue of performance share rights to Lewis Gradon.
Resolution 8: To approve the issue of options to Lewis Gradon.
Resolution 9: To approve the North America 2022 Employee Stock Purchase Plan.
Resolution 10: To approve the 2022 Performance Share Rights Plan – North America.
Resolution 11: To approve the 2022 Performance Share Option Plan – North America.
All resolutions were decided by poll. The details of the total number of votes cast online, via phone or
by proxy on the polls were as follows:

Resolution Votes
For
% Votes
Against
Abstain Total Votes
Cast
Resolution 1: To re-elect
Lewis Gradon as a director
417,970,319 99.99% 30,222 83,434 418,083,975
Resolution 2: To re-elect
Neville Mitchell as a director
411,128,146 98.36% 6,860,053 95,776 418,083,975
Resolution 3: To re-elect
Donal O’Dwyer as a director
410,700,203 98.28% 7,177,829 205,943 418,083,975
Resolution 4: To elect Lisa
McIntyre as a director
417,824,318 99.99% 56,047 203,610 418,083,975
Resolution 5: To elect Cather
Simpson as a director
417,779,788 99.97% 105,828 198,359 418,083,975
Resolution 6: To authorise the
Directors to fix the fees and
expenses of the auditor
412,820,609 99.30% 2,902,593 2,360,773 418,083,975
Resolution 7: To approve the
issue of performance share
rights to Lewis Gradon
406,452,228 97.42% 10,773,351 294,521 417,520,100
Resolution 8: To approve the
issue of options to Lewis
Gradon
406,325,338 97.39% 10,895,306 299,376 417,520,020
Resolution 9: To approve the
2022 Employee Stock
Purchase Plan
416,172,287 99.59% 1,715,840 195,848 418,083,975
Resolution 10: To approve the
2022 Performance Share
Rights Plan – North America
415,456,483 99.44% 2,358,647 267,250 418,082,380
Resolution 11: To approve the
2022 Performance Share
Option Plan – North America
416,914,483 99.81% 813,161 354,656 418,082,300

About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems
for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The
company’s products are sold in over 120 countries worldwide. For more information about the company,
visit our website www.fphcare.com.

Media & Investor Contacts:

Karen Knott
GM Corporate Communications
karen.knott@fphcare.co.nz
+64 21 713 911
Hayden Brown
Investor Relations Manager
hayden.brown@fphcare.co.nz
+64 27 807 8073

Authorised by Raelene Leonard, General Counsel & Company Secretary.